Lobbying Filing Details

Total Spending

$250,000

Activities

7

Lobbyists

1

Gov't Entities

63

Filing Information
Filing UUID:
9490f1c4-dafe-4509-9a66-e50d88711827
Type:
Q1 - 1st Quarter - Report
Period:
2020 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2020 at 7:04 PM
Income:
$0
Expenses:
$250,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Sarah Curtis
Registrant
MAYO CLINIC

Healthcare provider

Rochester, Minnesota
Client
MAYO CLINIC
Minnesota, United States of America
Lobbying Activities (7)
Activity 1
Health Issues

Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 2
Medical/Disease Research/Clinical Labs

Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 3
Medicare/Medicaid

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 4
Pharmacy

Drug shortages; drug pricing; 340B Program

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 5
Science/Technology

Telemedicine technology; New diagnostic tests, Precision medicine; NextGen sequencing

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 6
Transportation

Funding opportunities and planned improvements for the Rochester International Airport

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 7
Veterans

Reimbursement and coverage issues related to VA health care and Tricare

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.